Latest News

Genetic evidence that new therapies targeting Parkinson's disease may cause harm

Researchers have completed a small study that shows genetic and clinical evidence that therapies targeting the expression of alpha-synuclein -- a gene whose function is involved in the development and progression of Parkinson?s disease -- may accelerate disease progression and increase the risk of physical incapacitation and dementia. If replicated, the findings will have profound implications for therapies under development for Parkinson?s disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • First grade reading suffers in segregated schools

  • How can Britain be made more creative?

  • Children and hot cars a cause for deadly concern

  • Monoamine oxidase A: Biomarker for postpartum depression

  • Effect of loud noises on brain revealed in study

  • Pervasive implicit hierarchies for race, religion, age revealed by study

  • Internet search engines as both aid, danger for people at risk of suicide

  • How can we make Britain more creative?

  • Can summer camp be key to world peace?

  • Menu secrets that can make you slim by design

  •